Atrium Therapeutics RNA 深 滬
等待開盤 04-01 09:30:00 美东时间
13.37
-0.180
-1.33%
華盛通- 最 高13.53
- 今 開13.41
- 成交量 92.14万股
- 最 低 13.055
- 昨 收 13.55
- 總市值 2.07亿
- 52周最高 73.06
- 市盈率 靜 --
- 換手率 5.94%
- 52周最低 11.95
- 委 比 -95.75%
- 總股本 1551.50万
- 歷史最高 73.06
- 量 比 1.70
- 振 幅 3.51%
- 歷史最低 4.825
- 每 手 1
- 風險率 19.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Wells Fargo Initiates Coverage On Atrium Therapeutics with Overweight Rating, Announces Price Target of $25
Wells Fargo analyst Yanan Zhu initiates coverage on Atrium Therapeutics (NASDAQ:RNA) with a Overweight rating and announces Price Target of $25.
03-11 21:31
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
Avidity Biosciences ( ($RNA) ) has issued an update. Following the closing of a...
02-27 23:15
Novartis Acquires Avidity Biosciences At $72/Share In Cash
Novartis AG (NYSE:NVS) today announced that it has successfully completed its acquisition of Avidity Biosciences, Inc. ("Avidity"). With the completion of the acquisition, Avidity is now an indirect, wholly owned
02-27 22:06
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Applied Optoelectronics Inc (NASDAQ:AAOI) rose sharply in pre-market ...
02-27 17:43
美股盘前 | Block, Inc. Class A涨21.97%，戴尔涨12.56%
Block, Inc. Class A涨21.97%；戴尔涨12.56%；奈飞涨8.68%
02-27 17:23
Avidity Shareholders Approve Novartis Merger and Spin-Off
Avidity Biosciences ( ($RNA) ) has provided an announcement. At a special meeti...
02-27 07:26
Avidity posts FY 2025 net loss of USD 684.6 million (+112%)
Avidity posts FY 2025 net loss of USD 684.6 million (+112%) Avidity reported FY 2025 results showing revenue of USD 18.76 million and a net loss of USD 684.6 million. Research and development expenses were USD 559.16 million, while general and administrative expenses totaled USD 205.54 million; othe
02-24 05:09
Avidity Biosciences Advances Toward Novartis Merger Completion
Avidity Biosciences ( ($RNA) ) has shared an announcement. On February 23, 2026...
02-23 22:12
Avidity Biosciences Delays Shareholder Meeting Until Feb. 26
Avidity Biosciences Delays Shareholder Meeting Until Feb. 26 Avidity Biosciences Inc. said it plans to convene its special meeting of stockholders on Feb. 23, 2026 at 10:00 a.m. Eastern time and then immediately adjourn without conducting other business. The company said it expects to reconvene the
02-23 21:02
